At a biohacking conference this week, a biotech CEO dropped his pants and injected himself in the thigh with an experimental herpes treatment created by his company, leaving other biohackers worried.
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
A simple technique to gauge brain levels of a toxic protein could improve diagnosis and drug trials, to help in the quest to diagnose and treat Alzheimer’s disease.
Storing data in DNA is a lot easier than getting it back out, but a team of researchers has designed a system that could solve all these problems.
Researchers have developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests.
The flu alone is responsible for killing tens of thousands of people in the U.S., but scientists have revealed that they have designed a vaccine that could make seasonal flu protection far more effective.
A huge step towards one of the biggest goals in medicine has been taken, with the development of a universal blood test for cancer.
As the promise of liquid biopsies continues to impress, startups have already begun selling cheap cancer screening. But, still in its early stages, are they rushing it?
23andMe’s ancestry tests and those from three other companies produce drastically different results, according to Kristen Brown, writing for Gizmodo.
Microsoft thinks that artificial intelligence might be one way to fine-tune CRISPR, and resolve what scientists have been working on for a long while.
Roche Diagnostics and GE Healthcare have announced a collaboration aimed at developing a digital diagnostics platform providing clinical decision platform to support precision medicine.
In a new study, melanoma patients who received immunotherapy while taking a specific type of beta blocker lived longer than patients who received immunotherapy alone, researchers report.
Johnson & Johnson decided to kick start the new year by striking 15 new collaborations to drive the development of novel solutions to impact healthcare.